This site is intended for healthcare professionals only

CGM initiation within 1 year of diagnosis improves long-term glycaemic control

Initiating CGM early may set a better glycaemic trajectory, with effects on long-term diabetes outcomes.

This retrospective, observational study from a single centre in Colorado, US, has previously shown that initiation of continuous glucose monitoring (CGM) within the first year of type 1 diabetes diagnosis results in improved HbA1c compared with self-monitoring of blood glucose over 2.5 years of follow-up. The present analysis looked at outcomes in the same cohort after 7 years.

The medical records of 396 people newly diagnosed with type 1 diabetes between 2013 and the end of 2015 (the majority aged <18 years) were reviewed. Of these, 81 initiated CGM within 1 year and 315 did not. At 2.5 years’ follow-up, mean HbA1c was significantly lower in the CGM group (60 vs 78 mmol/mol [7.7% vs 9.3%]). At 7 years, this benefit had persisted (60 vs 84 mmol/mol [7.7% vs 9.8%]). The majority of participants were lost to follow-up at 7 years, with only seven in the original CGM group and 37 in the no-CGM group; nonetheless, the differences remained highly significant. Results did not differ after adjusting for age, sex, insulin delivery method, race and health insurance status.

A group of people who initiated CGM later than 1 year after diagnosis (n=47) was also evaluated. These individuals had a significant reduction in HbA1c compared with the no-CGM group at 7 years (69 vs 84 mmol/mol [8.5% vs 9.8%]); however, the mean HbA1c was still higher than in early initiators.

This study is limited by its single-centre design and the small number of participants at the final follow-up, and its retrospective design means that selection bias on the basis of health insurance coverage, socioeconomic status, diabetes education/knowledge and access to healthcare cannot be excluded. It is also notable that people who used their CGM device for less than 70% of the initial study period were excluded.

Despite these limitations, the authors conclude that use of CGM improves glycaemic control in people with type 1 diabetes, and that early initiation results in greater improvements. Initiating CGM early may set a better glycaemic trajectory, and this is important given the well-known effects of early glycaemic control on long-term diabetes outcomes.

Click here to read the study in full.

For the latest news and articles

Sign up to all DiabetesontheNet journals

© Copyright Omniamed Communications. All Rights Reserved​
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom​
Omniamed logo white
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

DiabetesontheNet Logo

This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.